Cloverleaf Bio
Cloverleaf Bio is seeking an experienced In Vivo Scientist to design and execute animal experiments, coordinate CRO studies, and perform cell culture work to advance novel RNA therapeutics targeting cancer. The role involves independent planning of in‑vivo studies, data analysis, and collaboration with the founding team to accelerate tRNA therapeutic development.
Cloverleaf Bio is a biotechnology company developing a new class of RNA therapeutics to revolutionize cancer therapy. The company recently raised a $33M seed round to advance its pipeline. It is currently hiring and actively growing its team.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cloverleaf Bio.
Cloverleaf Bio didn’t post a salary, so this is our estimate from similar listings.
25% below the average for this role